Clinical trials: Lifting Efficacy

Rhytids, Skin Laxity

Safety and Efficacy of 2910 nm Fiber Laser Resurfacing and Laser-Coring

• Active, not recruiting
• Age: 45 to 85 years
• Medical device

The primary objective of this clinical trial is to evaluate the safety and effectiveness of the 2,910 nm mid-infrared erbium-doped fluoride fiber glass laser (UltraClear, Acclaro Medical) for non-invasive dermatological aesthetic…

Trial name

NCT07254884

Testing

2,910 nm mid-infrared erbium-doped fluoride fiber glass laser (UltraClear, Acclaro Medical)

Where

United States

Volunteers

40 people

Sponsor

FA Corporation